Trial search
search
reset
more
Public title
Scientific title
Subject ID
Registration Status
Registration number
Secondary ID
Applicant
Study leader
Year
Primary sponsor
Secondary sponsor
Source(s) of funding
Target disease
Target disease code
Study type
Study phase
Study design
Recruiting status
Execute time(From)
Execute time(END)
Sign the informed consent
Gender
Nation(Area)
Province
City
Unit (hospital)
Institution
Level of the institution
Intervention
Intervention code
Approved by ethic committee
Calculated Results after the Study Completed puboptionc access
1 trials have been registered
Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR2200058477 Clinical efficacy and safety of Paxlovid in the treatment of severe adult patients with SARS-Cov-2 infection: a multicenter, randomized, controlled study

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Interventional study 2022/04/09